WO2006047841A2 - Engineering with homing factors - Google Patents
Engineering with homing factors Download PDFInfo
- Publication number
- WO2006047841A2 WO2006047841A2 PCT/BE2005/000158 BE2005000158W WO2006047841A2 WO 2006047841 A2 WO2006047841 A2 WO 2006047841A2 BE 2005000158 W BE2005000158 W BE 2005000158W WO 2006047841 A2 WO2006047841 A2 WO 2006047841A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- homing
- scaffold
- matrix
- factor
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
Definitions
- the invention accordingly relates to the use of homing factors to enhance the in vivo seeding on a scaffold suitable for replacing a disordered or diseased tissue or organ.
- the use of homing factors has particular advantages in the generation of scaffolds for implantation at a location which is under high shear stress, e.g. a scaffold for use in the cardiovascular system such as a heart valve or a vascular graft.
- the presence of one or more homing factors ensures the binding of one or more particular cell types to a matrix.
- tissue engineering more particularly tissue engineering of of vascular or lymphatic organs or other vessels such as the urethra, where the matrix is constantly in contact with fluid, such as the blood or lymph fluid and the cells therein
- the presence of homing agents alone can suffice to ensure the population of the matrix with the appropriate cells.
- the present invention demonstrates that homing factors can be used to physically and specifically link appropriate cells to a matrix of choice ( Figure 5).
- a particular embodiment of the present invention relates to scaffolds comprising homing factors.
- Figure 9 Percentage of (A) VLA-4+ (B) CD44+ and (C) CD172a+ cells present in the material during the different stages of the FBR. Dots and error bars represent average ⁇ standard deviation, a) significantly different from 6 hours (p ⁇ 0.05); b) significantly different from 6 hours, 1 , 2 and 3 days (p ⁇ 0.05); c) significantly different from 3 days (p ⁇ 0.05); d) significantly different from 2 days (p ⁇ 0.05).
- the 6 hours data are excluded from the statistical analysis because of 2 missing rat data.
- Cell binding and homing capacity is high, directly after implantation and is generally decreasing afterwards, except for a significant peak in CD172a+ cells at day 3.
- Figure 13 Presence of CD34+ cells (haematopoietic stem/progenitor cells) on patches implanted in sheep arteries.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Prostheses (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
- Filters For Electric Vacuum Cleaners (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Farming Of Fish And Shellfish (AREA)
- Emergency Lowering Means (AREA)
- Helmets And Other Head Coverings (AREA)
- Ladders (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005301111A AU2005301111B2 (en) | 2004-11-08 | 2005-11-08 | Scaffold engineering with homing factors |
| DE602005021908T DE602005021908D1 (de) | 2004-11-08 | 2005-11-08 | Engineering mit homing-faktoren |
| AT05808071T ATE471169T1 (de) | 2004-11-08 | 2005-11-08 | Engineering mit homing-faktoren |
| DK05808071.4T DK1812088T3 (da) | 2004-11-08 | 2005-11-08 | Konstruktion med homing-faktorer |
| CN2005800382236A CN101094697B (zh) | 2004-11-08 | 2005-11-08 | 用寻靶因子进行工程改造 |
| CA002582155A CA2582155A1 (en) | 2004-11-08 | 2005-11-08 | Scaffold engineering with homing factors |
| EP05808071A EP1812088B1 (en) | 2004-11-08 | 2005-11-08 | Engineering with homing factors |
| JP2007539427A JP4854670B2 (ja) | 2004-11-08 | 2005-11-08 | 構造骨格工学 |
| US11/745,953 US20070264306A1 (en) | 2004-11-08 | 2007-05-08 | Scaffold engineering |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0424560.1 | 2004-11-08 | ||
| GB0424560A GB0424560D0 (en) | 2004-11-08 | 2004-11-08 | Heart valve tissue engineering |
| US66076605P | 2005-03-11 | 2005-03-11 | |
| US60/660,766 | 2005-03-11 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/745,953 Continuation-In-Part US20070264306A1 (en) | 2004-11-08 | 2007-05-08 | Scaffold engineering |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006047841A2 true WO2006047841A2 (en) | 2006-05-11 |
| WO2006047841A3 WO2006047841A3 (en) | 2006-08-24 |
Family
ID=33523291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BE2005/000158 Ceased WO2006047841A2 (en) | 2004-11-08 | 2005-11-08 | Engineering with homing factors |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070264306A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2255834B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4854670B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101094697B (cg-RX-API-DMAC7.html) |
| AT (2) | ATE471169T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005301111B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2582155A1 (cg-RX-API-DMAC7.html) |
| DK (2) | DK1812088T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2385785T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0424560D0 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2255834T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006047841A2 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1797909A3 (en) * | 2005-11-28 | 2007-09-05 | Lifescan, Inc. | Compositons and methods to create a vascularized environment for cellular transplantation |
| EP2521565A1 (en) * | 2010-01-08 | 2012-11-14 | Baxter International Inc | Biomatrices to attract and retain regenerative and reparative cells |
| WO2022204315A1 (en) * | 2021-03-23 | 2022-09-29 | Terumo Bct, Inc. | Cell capture and expansion |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11051733B2 (en) * | 2008-01-18 | 2021-07-06 | Wake Forest University Health Sciences | Isolating and purifying cells for therapy |
| US20130245757A1 (en) * | 2011-11-04 | 2013-09-19 | Allergan, Inc. | Method and device for improved soft tissue surgery |
| MX2011013385A (es) * | 2009-06-11 | 2012-05-29 | Minerva Biotechnologies Corp | Metodos para cultivar celulas madre y celulas progenitoras. |
| WO2011022070A2 (en) | 2009-08-20 | 2011-02-24 | The Regents Of The University Of California | Perivascular stem cell composition for bone |
| EP4086338A1 (en) | 2011-03-17 | 2022-11-09 | Minerva Biotechnologies Corporation | Method for making pluripotent stem cells |
| WO2013009851A2 (en) * | 2011-07-11 | 2013-01-17 | The Children's Hospital Of Philadelphia | Oxidation resistant bioprosthetic tissues and preparation thereof |
| WO2013101720A1 (en) * | 2011-12-28 | 2013-07-04 | The Regents Of The University Of California | Implantable vascular devices and methods of use thereof |
| US11028502B2 (en) * | 2017-11-02 | 2021-06-08 | Wake Forest University Health Sciences | Vascular constructs |
| CN108187141A (zh) * | 2018-01-31 | 2018-06-22 | 广州沙艾生物科技有限公司 | 一种心脏肌球衍生细胞在生物材料中的应用 |
| CN110898254B (zh) * | 2019-12-17 | 2021-11-30 | 浙江大学 | 一种用于修复子宫内膜并提高生育力的生物活性支架 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2153097T3 (es) | 1995-04-07 | 2001-02-16 | Mogens Havsteen Jakobsen | Procedimiento de inmovilizacion fotoquimica de ligandos usando quinonas. |
| EP0991944B1 (en) | 1997-06-25 | 2004-08-25 | N.V. Innogenetics S.A. | Methods for covalent immobilisation of biomolecules to a carrier by means of a his-tag |
| EP1035879B1 (de) | 1997-11-24 | 2003-06-11 | EFMT Entwicklungs- und Forschungszentrum für Mikrotherapie gGmbH | Verfahren zur immobilisierung von mediatormolekülen auf anorganischen und metallischen implantatmaterialien |
| US6082364A (en) * | 1997-12-15 | 2000-07-04 | Musculoskeletal Development Enterprises, Llc | Pluripotential bone marrow cell line and methods of using the same |
| US6573101B1 (en) * | 1998-02-12 | 2003-06-03 | The Regents Of The University Of California | Compositions for receptor/liposome mediated transfection and methods of using same |
| WO2000023008A2 (en) * | 1998-10-20 | 2000-04-27 | Tissue Engineering, Inc. | Cardiovascular components for transplantation and methods of making thereof |
| DE19904975A1 (de) | 1999-02-06 | 2000-09-14 | Impella Cardiotech Ag | Vorrichtung zur intravasalen Herzklappenoperation |
| WO2001059455A2 (en) | 2000-02-08 | 2001-08-16 | Acspurt B.V. | Immobilization of bioactive species |
| US6652583B2 (en) * | 2000-04-07 | 2003-11-25 | Rhode Island Hospital | Cardiac valve replacement |
| CA2449978A1 (en) * | 2001-06-15 | 2002-12-27 | Johns Hopkins Singapore Pte Ltd | Biofunctional fibers |
| WO2004016283A2 (en) * | 2002-08-14 | 2004-02-26 | Avidis Sa | Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| JP2006508773A (ja) * | 2002-12-05 | 2006-03-16 | 株式会社カルディオ | 生体適合性組織片およびその利用 |
| US20040126405A1 (en) * | 2002-12-30 | 2004-07-01 | Scimed Life Systems, Inc. | Engineered scaffolds for promoting growth of cells |
| EP1611233B1 (en) * | 2003-04-08 | 2016-01-06 | Yeda Research And Development Co., Ltd. | Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| WO2005046746A2 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
-
2004
- 2004-11-08 GB GB0424560A patent/GB0424560D0/en not_active Ceased
-
2005
- 2005-11-08 DK DK05808071.4T patent/DK1812088T3/da active
- 2005-11-08 ES ES10165816T patent/ES2385785T3/es not_active Expired - Lifetime
- 2005-11-08 CN CN2005800382236A patent/CN101094697B/zh not_active Expired - Fee Related
- 2005-11-08 AU AU2005301111A patent/AU2005301111B2/en not_active Ceased
- 2005-11-08 EP EP10165816A patent/EP2255834B1/en not_active Expired - Lifetime
- 2005-11-08 WO PCT/BE2005/000158 patent/WO2006047841A2/en not_active Ceased
- 2005-11-08 ES ES05808071T patent/ES2347339T3/es not_active Expired - Lifetime
- 2005-11-08 JP JP2007539427A patent/JP4854670B2/ja not_active Expired - Fee Related
- 2005-11-08 DK DK10165816.9T patent/DK2255834T3/da active
- 2005-11-08 AT AT05808071T patent/ATE471169T1/de not_active IP Right Cessation
- 2005-11-08 AT AT10165816T patent/ATE556728T1/de active
- 2005-11-08 CA CA002582155A patent/CA2582155A1/en not_active Abandoned
- 2005-11-08 EP EP05808071A patent/EP1812088B1/en not_active Expired - Lifetime
- 2005-11-08 PL PL10165816T patent/PL2255834T3/pl unknown
-
2007
- 2007-05-08 US US11/745,953 patent/US20070264306A1/en not_active Abandoned
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1797909A3 (en) * | 2005-11-28 | 2007-09-05 | Lifescan, Inc. | Compositons and methods to create a vascularized environment for cellular transplantation |
| EP2521565A1 (en) * | 2010-01-08 | 2012-11-14 | Baxter International Inc | Biomatrices to attract and retain regenerative and reparative cells |
| WO2022204315A1 (en) * | 2021-03-23 | 2022-09-29 | Terumo Bct, Inc. | Cell capture and expansion |
| GB2619893A (en) * | 2021-03-23 | 2023-12-20 | Terumo Bct Inc | Cell capture and expansion |
| US12043823B2 (en) | 2021-03-23 | 2024-07-23 | Terumo Bct, Inc. | Cell capture and expansion |
Also Published As
| Publication number | Publication date |
|---|---|
| DK1812088T3 (da) | 2010-09-20 |
| ATE556728T1 (de) | 2012-05-15 |
| DK2255834T3 (da) | 2012-06-18 |
| ES2347339T3 (es) | 2010-10-28 |
| JP2008518606A (ja) | 2008-06-05 |
| WO2006047841A3 (en) | 2006-08-24 |
| ATE471169T1 (de) | 2010-07-15 |
| CN101094697A (zh) | 2007-12-26 |
| GB0424560D0 (en) | 2004-12-08 |
| EP2255834A1 (en) | 2010-12-01 |
| EP1812088B1 (en) | 2010-06-16 |
| AU2005301111A1 (en) | 2006-05-11 |
| AU2005301111B2 (en) | 2011-11-17 |
| PL2255834T3 (pl) | 2012-09-28 |
| EP1812088A2 (en) | 2007-08-01 |
| US20070264306A1 (en) | 2007-11-15 |
| JP4854670B2 (ja) | 2012-01-18 |
| CN101094697B (zh) | 2011-08-10 |
| ES2385785T3 (es) | 2012-07-31 |
| EP2255834B1 (en) | 2012-05-09 |
| CA2582155A1 (en) | 2006-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070264306A1 (en) | Scaffold engineering | |
| Cho et al. | Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices | |
| USRE42575E1 (en) | Engineering of strong, pliable tissues | |
| Mayer et al. | Tissue engineering of cardiovascular structures | |
| US7722671B1 (en) | Medical devices with associated growth factors | |
| Hayashida et al. | Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model | |
| US20050256588A1 (en) | Decellularized tissue | |
| US20040106991A1 (en) | Cardiac valve replacement | |
| CA2199810A1 (en) | Three-dimensional human cell cultures on cardiac valve frameworks and their uses | |
| AU2021245193B2 (en) | Regenerative tissue and natural tissue implants | |
| Inci et al. | Decellularized inner body membranes for tissue engineering: a review | |
| Lu et al. | Homologous and heterologous assessment of a novel biomaterial for venous patch | |
| Lutter et al. | Percutaneous tissue-engineered pulmonary valved stent implantation | |
| JP2008228744A (ja) | 生体由来移植用組織の石灰化を抑制するための処理方法および処理された組織 | |
| US20230174942A1 (en) | Novel fabrication of coronary based decellularized heart flaps to treat aneurysm following myocardial infarction | |
| Song et al. | Preparation and characterization of a de-cellularized rabbit aorta as a promising scaffold in vascular tissue engineering | |
| Burdick | Development of a tissue engineered heart valve | |
| Terlecki et al. | Tissue Engineering of the Urethra: The Basics, Current Concept, and the Future | |
| Culbreth | Fabrication and Characterization of an Extracellular Matrix Hydrogel for Aortic Valve Applications | |
| Assmann | Optimization of the biocompatibility of cardiovascular implants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2582155 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005301111 Country of ref document: AU |
|
| ENP | Entry into the national phase |
Ref document number: 2005301111 Country of ref document: AU Date of ref document: 20051108 Kind code of ref document: A |
|
| WWP | Wipo information: published in national office |
Ref document number: 2005301111 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007539427 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 11745953 Country of ref document: US Ref document number: 200580038223.6 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005808071 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2005808071 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 11745953 Country of ref document: US |